French National Registry of Children Born Small for Gestational Age Treated With Somatropin
Status:
Completed
Trial end date:
2018-10-09
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of the study is to describe the patient population
and therapeutic practices (study phase I), assess efficacy on growth and adult height and
assess tolerance of somatropin (Norditropin® SimpleXx®) (study phase II)